Comparison of the Accuracy of HSV1 and HSV2 Antibody Tests with PCR in the Diagnosis of Recurrent Genital Herpes
Jia Deng,Yu-Jian Ye,Qiu-Ping Chen,Yi-Jin Zhang,Ji-Feng Liu
DOI: https://doi.org/10.2147/ccid.s470020
2024-08-24
Clinical Cosmetic and Investigational Dermatology
Abstract:Jia Deng, Yu-Jian Ye, Qiu-Ping Chen, Yi-Jin Zhang, Ji-Feng Liu Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, People's Republic of China Correspondence: Ji-Feng Liu, Department of Dermatology, Hangzhou Third People's Hospital, No. 38 of West Lake Road, Shangcheng District, Hangzhou, Zhejiang, 310009, People's Republic of China, Tel/Fax +86 0571-87827514, Email Objective: To assess the accuracy of HSV1and HSV2 antibody testing in identifying genital herpes infection. Methods: A cohort of 299 patients previously diagnosed with recurrent genital herpes, confirmed via PCR, were tested using ELISA for HSV1 and HSV2 IgM and IgG antibodies. The study compared the accuracy of HSV1 and HSV2 antibody tests in diagnosing genital herpes. Results: Among 299 patients, 14 tested positives for HSV1 DNA. Of these, 9 had HSV1 IgG antibodies, but none had HSV2 IgG antibody. Among 278 patients with HSV2 DNA, 149 had HSV1 IgG, 9 had HSV2 IgG, and 97 had both. Seven patients had both HSV1 and HSV2 DNA; 3 had HSV1 IgG, 1 had HSV2 IgG, and 3 had both. The accuracy of HSV1 IgG for HSV1 infection was 64.2%, and for HSV1 and HSV2 co-infection, 85.7%. The accuracy of HSV2 IgG for HSV2 infection was 38.1%, and for HSV1 and HSV2 co-infection, 57.1%. The combined antibody positivity accuracy was 34.9%. Conclusion: Genital herpes is primarily caused by HSV2 (92.98%). A smaller percentage is HSV1 (4.67%) or co-infection (2.34%). Despite relatively low diagnostic accuracy (34.9– 85.7%) for antibody detection, combined antibody testing is necessary. Herpes DNA testing is recommended for accurate diagnosis. Absence of antibodies does not rule out genital herpes and clinical assessment is essential. Keywords: antibody test, DNA test, genital herpes, HSV-1, HSV-2 Genital herpes (GH) is a sexually transmitted infection characterized by recurring outbreaks, predominantly affecting the genital region and adjacent skin and mucous membranes. In the United States, about 1 in every 6 people ages 14 to 49 has genital herpes, the positivity rate of herpes antibody testing can be influenced by factors such as the timing of the test relative to infection onset, individual immune response variability, and potential genetic mutations affecting antibody production. GH is caused by the herpes simplex virus (HSV), which can be classified into HSV-1 and HSV-2 serotypes. GH is predominantly attributed to HSV-2 infection; however, the annual incidence of GH induced by HSV-1 infection is on the rise, correlating with shifts in sexual behavior. 1 Since the latent infection of HSV cannot be completely eliminated from the body at present, the disease duration is protracted and the disease tends to relapse, causing great suffering to patients. GH-induced genital ulcers significantly increase the transmission of syphilis and human immunodeficiency viruses (HIV), 2,3 and HSV has a synergistic pathogenic effect with HIV. 4 Female patients have an increased risk of developing cervical cancer, and HSV infection during pregnancy carries the possibility of fetal malformations. Newborns can be infected with the virus during delivery and develop diseases, such as herpesvirus encephalitis, resulting in disability or death. 5 Therefore, GH is a public health concern that seriously threatens the health of patients, and requires accurate diagnosis and standardized treatment. Currently, the laboratory diagnosis of GH primarily involves virus culture, serum antibody testing, antigen testing, and polymerase chain reaction (PCR). The operability, periodicity, positivity rate, and sensitivity of different assays vary. Among these methods, herpes virus antibody testing is convenient and fast. It can be used for epidemiological investigation of asymptomatic patients and has a wide range of clinical applications. It is recommended to conduct tests that can differentiate between HSV1 and HSV2 infections, as patients infected with different types of HSV have varying prognoses and require different follow-up measures. 6 Antibodies against structural glycoprotein G (gG-1 in HSV-1 and gG-2 in HSV-2) are used clinically for serotyping. 7 Nevertheless, the positivity rate for HSV-2 detection is comparatively low. Van Rooijen et al 6 reported a positivity rate of 69.70% for HSV-2 antibody; however, the number of cases is relatively small, only 33 individuals. Hence, we included a cohort of 299 patients with recurrent GH who exhibited positive results in HSV DNA testing. Subsequently, these patients were assessed for the presence of HSV1 and HSV2 IgG antibodies. By comparing the accuracy of HSV1 and HSV2 IgG antibody tests with DNA test by fluorescence quantitative PCR, this study seeks to provide a more comprehensive -Abstract Truncated-
dermatology